Clinical Trial Update: Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the safety and efficacy of palmitoylethanolamide (PEA) and polydatin for irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Palmitoylethanolamide (palmitoylethanolamide)
• Polydatin (polydatin)

Snippet

Sponsor: MARIA CRISTINA COMELLI | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN